Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya.
Genital tract infections
Kenya
Lower genital tract symptoms
Performance
Syndromic treatment
Vaginal discharge
Vaginitis
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
17
11
2022
accepted:
04
07
2023
medline:
24
8
2023
pubmed:
23
8
2023
entrez:
23
8
2023
Statut:
epublish
Résumé
Genital tract infections pose a public health concern. In many low-middle-income countries, symptom-based algorithms guide treatment decisions. Advantages notwithstanding, this strategy has important limitations. We aimed to determine the infections causing lower genital tract symptoms in women, evaluated the Kenyan syndromic treatment algorithm for vaginal discharge, and proposed an improved algorithm. This cross-sectional study included symptomatic non-pregnant adult women presenting with lower genital tract symptoms at seven outpatient health facilities in Nairobi. Clinical, socio-demographic information and vaginal swabs microbiological tests were obtained. Multivariate logistic regression analyses were performed to find predictive factors for the genital infections and used to develop an alternative vaginal discharge treatment algorithm (using 60% of the dataset). The other 40% of data was used to assess the performance of each algorithm compared to laboratory diagnosis. Of 813 women, 66% had an infection (vulvovaginal candidiasis 40%, bacterial vaginosis 17%, Neisseria gonorrhoea 14%, multiple infections 23%); 56% of women reported ≥ 3 lower genital tract symptoms episodes in the preceding 12 months. Vulvovaginal itch predicted vulvovaginal candidiasis (odds ratio (OR) 2.20, 95% CI 1.40-3.46); foul-smelling vaginal discharge predicted bacterial vaginosis (OR 3.63, 95% CI 2.17-6.07), and sexually transmitted infection (Neisseria gonorrhoea, Trichomonas vaginalis, Chlamydia trachomatis, Mycoplasma genitalium) (OR 1.64, 95% CI 1.06-2.55). Additionally, lower abdominal pain (OR 1.73, 95% CI 1.07-2.79) predicted sexually transmitted infection. Inappropriate treatment was 117% and 75% by the current and alternative algorithms respectively. Treatment specificity for bacterial vaginosis/Trichomonas vaginalis was 27% and 82% by the current and alternative algorithms, respectively. Performance by other parameters was poor to moderate and comparable between the two algorithms. Single and multiple genital infections are common among women presenting with lower genital tract symptoms at outpatient clinics in Nairobi. The conventional vaginal discharge treatment algorithm performed poorly, while the alternative algorithm achieved only modest improvement. For optimal care of vaginal discharge syndrome, we recommend the inclusion of point-of-care diagnostics in the flowcharts.
Sections du résumé
BACKGROUND
BACKGROUND
Genital tract infections pose a public health concern. In many low-middle-income countries, symptom-based algorithms guide treatment decisions. Advantages notwithstanding, this strategy has important limitations. We aimed to determine the infections causing lower genital tract symptoms in women, evaluated the Kenyan syndromic treatment algorithm for vaginal discharge, and proposed an improved algorithm.
METHODS
METHODS
This cross-sectional study included symptomatic non-pregnant adult women presenting with lower genital tract symptoms at seven outpatient health facilities in Nairobi. Clinical, socio-demographic information and vaginal swabs microbiological tests were obtained. Multivariate logistic regression analyses were performed to find predictive factors for the genital infections and used to develop an alternative vaginal discharge treatment algorithm (using 60% of the dataset). The other 40% of data was used to assess the performance of each algorithm compared to laboratory diagnosis.
RESULTS
RESULTS
Of 813 women, 66% had an infection (vulvovaginal candidiasis 40%, bacterial vaginosis 17%, Neisseria gonorrhoea 14%, multiple infections 23%); 56% of women reported ≥ 3 lower genital tract symptoms episodes in the preceding 12 months. Vulvovaginal itch predicted vulvovaginal candidiasis (odds ratio (OR) 2.20, 95% CI 1.40-3.46); foul-smelling vaginal discharge predicted bacterial vaginosis (OR 3.63, 95% CI 2.17-6.07), and sexually transmitted infection (Neisseria gonorrhoea, Trichomonas vaginalis, Chlamydia trachomatis, Mycoplasma genitalium) (OR 1.64, 95% CI 1.06-2.55). Additionally, lower abdominal pain (OR 1.73, 95% CI 1.07-2.79) predicted sexually transmitted infection. Inappropriate treatment was 117% and 75% by the current and alternative algorithms respectively. Treatment specificity for bacterial vaginosis/Trichomonas vaginalis was 27% and 82% by the current and alternative algorithms, respectively. Performance by other parameters was poor to moderate and comparable between the two algorithms.
CONCLUSION
CONCLUSIONS
Single and multiple genital infections are common among women presenting with lower genital tract symptoms at outpatient clinics in Nairobi. The conventional vaginal discharge treatment algorithm performed poorly, while the alternative algorithm achieved only modest improvement. For optimal care of vaginal discharge syndrome, we recommend the inclusion of point-of-care diagnostics in the flowcharts.
Identifiants
pubmed: 37608250
doi: 10.1186/s12879-023-08442-2
pii: 10.1186/s12879-023-08442-2
pmc: PMC10463802
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
547Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Curr Infect Dis Rep. 2017 Jan;19(1):3
pubmed: 28210940
BMC Infect Dis. 2019 Oct 22;19(1):879
pubmed: 31640583
Lancet Infect Dis. 2019 Jun;19(6):658-669
pubmed: 31031172
Clin Infect Dis. 2021 May 4;72(9):1538-1543
pubmed: 32350529
Sex Transm Dis. 2018 Jun;45(6):422-428
pubmed: 29465674
BMJ Open. 2019 Dec 15;9(12):e031543
pubmed: 31843827
Dtsch Arztebl Int. 2020 Feb 21;116(8):126-133
pubmed: 32181734
Infect Dis (Auckl). 2019 May 31;12:1178633719851825
pubmed: 31210732
Sex Health. 2018 Feb;15(1):1-12
pubmed: 28838352
Pan Afr Med J. 2021 Nov 04;40:138
pubmed: 34909106
AJOG Glob Rep. 2021 Dec 04;2(1):100037
pubmed: 36274971
BMC Public Health. 2021 May 3;21(1):850
pubmed: 33941131
Reprod Health. 2008 Jul 03;5:3
pubmed: 18598359
S Afr Med J. 2018 Oct 02;108(10):876-880
pubmed: 30421718
Trop Med Int Health. 2016 Sep;21(9):1138-46
pubmed: 27350659
Sex Transm Infect. 2000 Feb;76(1):33-8
pubmed: 10817066
Sex Transm Infect. 2020 Aug;96(5):342-347
pubmed: 32241905
Sci Rep. 2022 Nov 25;12(1):20325
pubmed: 36434126
PLoS One. 2018 Apr 24;13(4):e0196209
pubmed: 29689080
BMC Med Inform Decis Mak. 2015 Dec 16;15:106
pubmed: 26674351
PLoS One. 2019 Jan 10;14(1):e0210421
pubmed: 30629655
Trop Med Int Health. 2009 Jun;14(6):703-8
pubmed: 19392745
Int J STD AIDS. 2014 Oct;25(12):851-9
pubmed: 24516075
Sex Transm Infect. 2019 Feb;95(1):60-66
pubmed: 30228109
Am J Epidemiol. 2017 Jul 15;186(2):194-201
pubmed: 28472225
Bull World Health Organ. 2007 Apr;85(4):297-304
pubmed: 17546311
Sex Transm Dis. 2014 Feb;41(2):123-8
pubmed: 24413493
Sex Transm Dis. 2009 Jun;36(6):357-64
pubmed: 19434010
Sex Transm Dis. 2019 Jul;46(7):458-464
pubmed: 31194717
Infect Dis Obstet Gynecol. 2019 Jul 15;2019:8639510
pubmed: 31379424
BMC Infect Dis. 2018 Oct 3;18(1):499
pubmed: 30285705